← DeepTechTracker
Auvi Labs' product rendering of its Beacon ultrasound monitoring device on an arm. Investigational use only.

Auvi Labs raises $1.4 million for wearable ultrasound monitoring

Beacon product rendering: Auvi Labs. Investigational device, not cleared for sale.

Auvi Labs is developing a patch that measures blood flow with ultrasound without someone having to hold a scanner against the body. The Chicago-based startup has closed an oversubscribed $1.4 million pre-seed round, chief executive and co-founder Rishab Veldur announced on November 17. Its first application is monitoring the access point used by people receiving dialysis.

For many dialysis patients, that access point is a fistula, a surgical connection between an artery and a vein that lets blood flow to the dialysis machine. A narrowing or blockage can disrupt treatment. Auvi's Beacon system is designed to track blood flow and alert clinicians when it changes, giving them information between checks performed with a handheld ultrasound probe.

The company describes a combination of flexible ultrasound hardware, wireless transmission and software that follows changes in blood flow over time. Ultrasound uses sound waves to measure what is happening inside the body. Here, the aim is to collect those measurements from a device worn on the skin and send them to the care team, rather than requiring an operator to hold and position a probe for each reading.

Beacon grew out of a capstone project at the University of Illinois and Carle Illinois College of Medicine. The founding team is Veldur, chief technology officer Satyansh Yeluri, chief operating officer Kevin Volkema and chief marketing officer Richie Li. The university reported in August that the team had refined hardware and software prototypes and planned a first pilot at Carle Foundation Hospital in Urbana.

In his funding announcement, Veldur said Auvi was rolling out pilot studies in dialysis, heart failure and surgical oncology. The Daily Illini reported in November that the company had received approval to begin recruiting patients. These are steps toward testing the system in clinical use. Beacon remains for investigational use only and is not cleared for sale by the US Food and Drug Administration or any other regulatory authority, according to the founder.

The announcement names Heinz Ventures, Mintaka VC, Illinois Ventures, Angels at Illinois Ventures, Chicago Early Growth Ventures, the Illinois Department of Commerce and Economic Opportunity, Husker Venture Fund and individual angels among Auvi's backers. Heinz Ventures separately identifies Auvi as a portfolio company and says Eric Heinz is its board chair. The immediate work is clinical evaluation of the monitoring system, rather than a commercial launch.

Read at source ↗

Funding amount, pre-seed stage, backer list and investigational status: founder announcement, November 17. Technology descriptions are company claims; the university documents prototypes and planned pilots. No clinical benefit or product-specific patent licence is established. The backer list does not establish a lead investor or the split between private investment and public support. Image is an official product rendering, not a clinical trial photograph.

Additional reporting

What it does

Develops Beacon, a wearable ultrasound system designed to measure blood flow and alert clinicians to changes, starting with dialysis access monitoring.

Round

$1.4 million pre-seed announced November 17 by the founder. Lead investor not specified.

Backers named

Heinz Ventures, Mintaka VC, Illinois Ventures, Angels at Illinois Ventures, Chicago Early Growth Ventures, Illinois Department of Commerce and Economic Opportunity, Husker Venture Fund, Individual angels.

Clinical work

Pilot studies in dialysis, heart failure and surgical oncology, according to the founder. No patient outcomes established by this funding announcement.

Status

For investigational use only. Not cleared for sale by the FDA or any other regulatory authority.

Base

Chicago, United States.

Browse more DeepTech news →

Who's raising. Who's funding. What's next in DeepTech.